It has been shown that tumor-derived TGF-β inhibits the migration of DCs from tumors to their draining LNs, and that this immunosuppressive effect of TGF-β increases the risk of metastasis in the affected nodes 35. The gene discussed is TGFB1; the disease is neoplasm.